Cardiac markers: point of care testing

Area of Science:

• Clinical Diagnostics
• Biomedical Engineering
• Emergency Medicine

Background:

• Point-of-care (POC) testing enables diagnostic assays near the patient, such as in emergency departments.
• Current POC immunoassays for cardiac markers (CK-MB, myoglobin, troponin I, troponin T) provide results comparable to central lab assays.
• POC cardiac markers may enhance triage and outcomes for emergency room patients with chest pain.

Purpose of the Study:

• To evaluate the impact of POC cardiac marker testing on patient outcomes and care processes.
• To assess the diagnostic accuracy and prognostic value of POC troponin assays.
• To explore how POC testing influences clinical decision-making and resource utilization.

Main Methods:

• Review of existing literature on POC cardiac marker assays.
• Analysis of studies evaluating POC troponin I and troponin T assays.
• Examination of the role of POC testing in managing patients with suspected acute myocardial infarction.

Main Results:

• POC assays for myoglobin and CK-MB show high sensitivity and specificity for acute myocardial infarction.
• POC troponin T assays are well-studied and, with troponin I, offer sensitive myocardial injury identification.
• POC testing has the potential to improve triage, treatment, and resource utilization.

Conclusions:

• POC cardiac marker testing, particularly for troponins, aids in early and sensitive diagnosis of myocardial injury.
• Implementing POC tests within improved triage and treatment strategies can enhance patient outcomes.
• Further research is needed to definitively establish the impact of POC testing on patient outcomes and care processes.